Quillivant XR 25 MG/5 ML susp 180ML
Ended Awarded
- Contract number
- SPE2DB25FSGBM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,118
Award facts
- Contract value 100% obligated
- $1,118.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml) at a ceiling value of $1,118.30. This delivery order represents a firm fixed-price procurement with no set-aside designation, issued under a competitive process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's substantial prime IDV vehicle enables it to provide a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally. This specific delivery order for Quillivant XR—an extended-release liquid formulation of methylphenidate used to treat attention-deficit/hyperactivity disorder—reflects AmerisourceBergen's role in supplying essential medications across multiple therapeutic domains to the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FSGBM?
SPE2DB25FSGBM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FSGBM worth?
The government has obligated $1,118 on SPE2DB25FSGBM.
Is contract SPE2DB25FSGBM an order under another contract?
Yes. SPE2DB25FSGBM is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGBM competed?
The extent of competition for SPE2DB25FSGBM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award